000 02486nam  2200349za 4500
0019.832849
003CaOODSP
00520221107150059
007cr |||||||||||
008170222s2017    onc     ob   f000 0 eng d
022 |z1925-0630
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-5/2017-2E-PDF|zH113-5/2017-2E
24500|aSpecial review decision |h[electronic resource] : |bsimazine.
260 |aOttawa : |bHealth Canada, |c2017.
300 |a12 p.
4901 |aRe-evaluation note, |x1925-0649 ; |vREV2017-02
500 |aIssued also in French under title: Décision d’examen spécial concernant la simazine.
500 |aCover title.
500 |a"10 February 2017."
504 |aIncludes bibliographical references.
520 |a"Pursuant to subsection 17(2) of the Pest Control Products Act, the Pest Management Regulatory Agency (PMRA) conducted a special review of pest control products containing simazine based on the decisions taken by Norway in 1998 and by the European Commission in 2004 to prohibit all uses of simazine due to environmental concerns. The PMRA evaluated the aspects of concern that prompted the special review in accordance with subsection 18(4) of the Pest Control Products Act. The proposed special review decision was published for consultation in the Re-evaluation Note REV2016-09, Special Review of Simazine: Proposed Decision for Consultation, and it outlines the Agency’s proposed decision and the reasons for it. Comments received during the consultation process were taken into consideration in making this final special review decision, and they did not result in changes to the proposed regulatory decision as described in REV2016-09. Therefore, the PMRA, under the authority of the Pest Control Products Act, is confirming the current registration of pest control products containing simazine in Canada"--Special review decision, p. 1.
530 |aIssued also in print format.
69207|2gccst|aPesticides
69207|2gccst|aCertification
69207|2gccst|aToxicology
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tDécision d’examen spécial concernant la simazine |w(CaOODSP)9.832850
830#0|aRe-evaluation note (Canada. Pest Management Regulatory Agency)|x1925-0649 ; |vREV2017-02|w(CaOODSP)9.504460
85640|qPDF|s164 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-5/H113-5-2017-2-eng.pdf